These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8043222)

  • 1. A risk-benefit assessment of conventional versus intensive insulin therapy.
    Reichard P
    Drug Saf; 1994 Mar; 10(3):196-202. PubMed ID: 8043222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years.
    Reichard P; Berglund B; Britz A; Cars I; Nilsson BY; Rosenqvist U
    J Intern Med; 1991 Aug; 230(2):101-8. PubMed ID: 1865159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    Ophthalmology; 1995 Apr; 102(4):647-61. PubMed ID: 7724182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemia control in diabetes mellitus. Towards the normal profile?
    Zimmerman BR
    Drugs; 1994 Apr; 47(4):611-21. PubMed ID: 7516860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up.
    Reichard P; Pihl M; Rosenqvist U; Sule J
    Diabetologia; 1996 Dec; 39(12):1483-8. PubMed ID: 8960830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensified conventional insulin treatment and neuropsychological impairment.
    Reichard P; Britz A; Rosenqvist U
    BMJ; 1991 Dec; 303(6815):1439-42. PubMed ID: 1773148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic control and complications over 3 years in patients with insulin dependent diabetes (IDDM): the Stockholm Diabetes Intervention Study (SDIS).
    Reichard P; Britz A; Carlsson P; Cars I; Lindblad L; Nilsson BY; Rosenqvist U
    J Intern Med; 1990 Nov; 228(5):511-7. PubMed ID: 2254723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M; Kishikawa H; Ohkubo Y; Wake N
    Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and retinopathy.
    Reichard P; Rosenqvist U
    J Intern Med; 1989 Aug; 226(2):81-7. PubMed ID: 2671247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.
    Am J Med; 1991 Apr; 90(4):450-9. PubMed ID: 2012085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Lammert M; Nicklasson L; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S67-73. PubMed ID: 15324518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study.
    Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Sandvik L; Aagenaes O
    Br Med J (Clin Res Ed); 1985 Mar; 290(6471):811-5. PubMed ID: 3919804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs of intensive insulin therapy in type 1 diabetes mellitus. Experiences from the DCCT study].
    Szucs TD; Smala AM; Fischer T
    Fortschr Med; 1998 Nov; 116(31):34-8. PubMed ID: 9864894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Diabetes Control and Complications Trial (DCCT).
    Keen H
    Health Trends; 1994; 26(2):41-3. PubMed ID: 10137725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Stockholm Diabetes Intervention Study (SDIS): 18 months' results.
    Reichard P; Britz A; Cars I; Nilsson BY; Sobocinsky-Olsson B; Rosenqvist U
    Acta Med Scand; 1988; 224(2):115-22. PubMed ID: 3048052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.